Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer

Sponsor
Centre Hospital Regional Universitaire de Limoges
Study ID
NCT00559676
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • capecitabine — DRUG
  • fluorouracil — DRUG
  • irinotecan hydrochloride — DRUG
  • leucovorin calcium — DRUG
  • oxaliplatin — DRUG
  • laboratory biomarker analysis — OTHER
  • pharmacological study — OTHER

Study Details

RATIONALE: Studying samples of blood and tumor tissue in the laboratory from patients with cancer receiving chemotherapy may help doctors understand the effect of chemotherapy on biomarkers. It may also help doctors predict how patients will respond to treatment. PURPOSE: This phase IV trial is studying biomarkers in patients undergoing chemotherapy for metastatic colorectal cancer.

Key Dates

Start date
Mar 31, 2005
Status verified
Jul 2009
Primary completion
May 31, 2011

Study Design

Enrollment
200 participants (estimated)
Allocation
NON_RANDOMIZED
Primary purpose
TREATMENT

Primary Outcome Measure

Oncogenetic parameters

Related Studies